CanSino Biologics Dividend

Dividend criteria checks 0/6

CanSino Biologics does not currently pay a dividend.

Key information

0%

Dividend yield

0%

Payout ratio

Industry average yield1.2%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Earnings per share-HK$6.13
Dividend yield forecast in 3Y0%

Recent dividend updates

Recent updates

The Consensus EPS Estimates For CanSino Biologics Inc. (HKG:6185) Just Fell Dramatically

Apr 07
The Consensus EPS Estimates For CanSino Biologics Inc. (HKG:6185) Just Fell Dramatically

Is CanSino Biologics (HKG:6185) Weighed On By Its Debt Load?

Feb 06
Is CanSino Biologics (HKG:6185) Weighed On By Its Debt Load?

CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?

Oct 13
CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?

Analysts Are More Bearish On CanSino Biologics Inc. (HKG:6185) Than They Used To Be

Sep 07
Analysts Are More Bearish On CanSino Biologics Inc. (HKG:6185) Than They Used To Be

CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?

May 12
CanSino Biologics (HKG:6185) Has Debt But No Earnings; Should You Worry?

Does CanSino Biologics (HKG:6185) Have A Healthy Balance Sheet?

Jan 09
Does CanSino Biologics (HKG:6185) Have A Healthy Balance Sheet?

CanSino Biologics Inc.'s (HKG:6185) Share Price Not Quite Adding Up

Sep 16
CanSino Biologics Inc.'s (HKG:6185) Share Price Not Quite Adding Up

Things Look Grim For CanSino Biologics Inc. (HKG:6185) After Today's Downgrade

Aug 31
Things Look Grim For CanSino Biologics Inc. (HKG:6185) After Today's Downgrade

Should You Be Adding CanSino Biologics (HKG:6185) To Your Watchlist Today?

Aug 29
Should You Be Adding CanSino Biologics (HKG:6185) To Your Watchlist Today?

Analysts Just Made A Major Revision To Their CanSino Biologics Inc. (HKG:6185) Revenue Forecasts

Jul 13
Analysts Just Made A Major Revision To Their CanSino Biologics Inc. (HKG:6185) Revenue Forecasts

Is CanSino Biologics (HKG:6185) Using Too Much Debt?

Jul 01
Is CanSino Biologics (HKG:6185) Using Too Much Debt?

We Think CanSino Biologics (HKG:6185) Can Stay On Top Of Its Debt

Mar 15
We Think CanSino Biologics (HKG:6185) Can Stay On Top Of Its Debt

CanSino Biologics Inc. (HKG:6185) Analysts Just Slashed Next Year's Revenue Estimates By 15%

Jan 11
CanSino Biologics Inc. (HKG:6185) Analysts Just Slashed Next Year's Revenue Estimates By 15%

Are Investors Undervaluing CanSino Biologics Inc. (HKG:6185) By 20%?

Dec 26
Are Investors Undervaluing CanSino Biologics Inc. (HKG:6185) By 20%?

CanSino Biologics (HKG:6185) Seems To Use Debt Quite Sensibly

Oct 01
CanSino Biologics (HKG:6185) Seems To Use Debt Quite Sensibly

CanSino Biologics' (HKG:6185) Earnings Aren't As Good As They Appear

Sep 05
CanSino Biologics' (HKG:6185) Earnings Aren't As Good As They Appear

Is CanSino Biologics (HKG:6185) Using Debt In A Risky Way?

Jul 03
Is CanSino Biologics (HKG:6185) Using Debt In A Risky Way?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if 6185's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 6185's dividend payments have been increasing.


Dividend Yield vs Market

CanSino Biologics Dividend Yield vs Market
How does 6185 dividend yield compare to the market?
SegmentDividend Yield
Company (6185)0%
Market Bottom 25% (HK)3.2%
Market Top 25% (HK)8.0%
Industry Average (Biotechs)1.2%
Analyst forecast in 3 Years (6185)0%

Notable Dividend: Unable to evaluate 6185's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 6185's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: 6185 is not paying a notable dividend for the Hong Kong market.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 6185 has not reported any payouts.


Discover strong dividend paying companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.